RIOUX PATRICE 4
4 · Monopar Therapeutics · Filed Nov 26, 2019
Insider Transaction Report
Form 4
RIOUX PATRICE
Other
Transactions
- Exercise/Conversion
Common Stock
2019-11-26$6.00/sh+18,333$109,998→ 18,333 total - Exercise/Conversion
Common Stock
2019-11-26$0.00/sh+100$0→ 18,433 total - Exercise/Conversion
Stock options
2019-11-26−18,333→ 13,671 totalExercise: $6.00Exp: 2027-12-31→ Common Stock (18,333 underlying) - Exercise/Conversion
Stock options
2019-11-26−100→ 6,900 totalExercise: $0.00Exp: 2026-12-14→ Common Stock (100 underlying)
Holdings
- 20,000
Stock options
Exercise: $6.00Exp: 2028-12-30→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]Original stock options to purchase up to 32,004 shares of common stock vested 12,000 shares upon grant date of January 1, 2018 and 1,667 shares on the first of each month thereafter.
- [F2]Original stock options to purchase up to 7,000 shares of common stock vested: 1,190 shares on January 15, 2017; 1,120 shares on February 15, 2017; 1,190 shares on March 15, 2017; 1,120 shares on April 15, 2017; 1,190 shares on May 15, 2017; and 1,190 shares on June 15, 2017.
- [F3]Stock options to purchase up to 20,000 shares of common stock vests 1,667 on January 31, 2019 and the last day of each subsequent month thereafter.